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ABSTRACT 
A CLINICAL STUDY OF FETO-MATERNAL OUTCOME IN 
PREGNANCIES WITH ABNORMAL LIQUOR VOLUME 
AIMS AND OBJECTIVES: 
To study the obstetric and perinatal outcome in pregnancies complicated 
with abnormal liquor volume and to detect the etiological factors  responsible 
for causing abnormal liquor volume. 
MATERIALS AND METHODS: 
 This descriptive study was conducted at Institute Of Obstetrics and 
Gynaecology, egmore, Chennai from October 2012 to September 2013. In this 
study, pregnant women with singleton, gestational age between 28- 42 weeks 
with oligohydramnios (AFI ≤ 5) and polyhydramnios (≥ 25) were taken as a 
study population. They were subjected to detailed history, clinical examination 
and ultrasound examination with Doppler and they were followed up through 
out the pregnancy and their fetal and maternal outcome were studied.  
RESULTS: 
 Most of the women with abnormal liquor volume were presented at term. 
Isolated oligohydramnios (37.33%) was the most common cause followed by 
post dated pregnancy (28.67%) in oligohydramnios group. Incidence of 
congenital anomalies were high in polyhydramnios (22%) than in 
oligohydramnios (4%). Incidence of induction of labour (65.33%), cesarean 
section(59.33%), fetal distress(76.4%), meconium stained liquor(57.33%), 
low 5 minutes APGAR, low birth weight(54%), IUGR(18.66%) and NICU 
admission(50.66%) were common in oligohydramnios group. 
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 Idiopathic polyhydramnios (58%) were the first common cause of 
polyhydramnios, the second were congenital anomalies( 22%). Incidence of 
PROM(44.5%), preterm labour(14%), cord prolapse(6%),atonic PPH (4%), 
retained placenta(2%) were common in polyhydramnios group. Perinatal 
mortality were high in polyhydramnios than in oligohydramnios group.  
CONCLUSION: 
Isolated oligo and polyhydramnios in term gestation has better perinatal 
outcome compared to early onset and with associated  conditions like 
hypertensive diseases of pregnancy, GDM, IUGR. A detailed history, clinical 
examination  and relevant investigations should be done to identify the various   
etiological factors in all cases of abnormal liquor volume, to get better  foetal 
outcome as well as to avoid  the maternal complications. 
KEYWORDS: 
Pregnancy, Oligohydramnios, Polyhydramnios, congenital anomalies, 
perinatal outcome. 
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INTRODUCTION 
As our ancestors crawled out of the ocean to life on land, We too, 
float in the amniotic fluid until birth.  The Amniotic fluid starts its origin 
from the maternal plasma by transudation as early as from the  seventh 
week of gestation. Its amount varies throughout the  pregnancy.  The 
Amniotic fluid performs several functions during the intrauterine life. It 
helps to shape the fetal skeleton normally by creating the physical space, 
promotes fetal lung maturation and  protects the umbilical cord from the 
compression during labour. Too much or  too little amount of amniotic 
fluid is the most common clinically detectable intrinsic abnormality1 
which was  the of basis of our study. 
Before the era of the invent of ultrasound use in obstetrics, the 
amniotic fluid volume was assessed clinically by the bimanual palpation 
and symphysio-fundal height which was found to be unreliable 
subsequently. In 1950, Prof.sir. Ian donald2  was the first to demonstrate 
and document the application of ultrasound to medical diagnosis. In 
modern obstetrics, ultrasound is an integral part of the obstetrician’s 
armamentarium- almost an extension of the examining finger, because of 
its non invasive nature, accuracy and repeatability. 
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The  Amniotic fluid volume assessment is an integral part of the  
antepartum fetal surveillance because of its abnormality is an indicator of  
poor perinatal outcome. Various ultrasound methos has been proposed for 
the detection of amniotic fluid, among which the amniotic fluid 
index(AFI) is the most widely used method.  J.P. phelan3 and  colleagues 
in 1987 proposed  this method. According to him, the  amniotic fluid 
volume was  categorized  as  follows, 
           Normal  8-24 cm 
Borderline 5-8 cm 
Oligohydramnios ≤ 5 
Polyhydramnios ≥ 25 
  
Oligohydramnios  is recently defined as AFI below 5th percentile 
for the gestational age. Post dated pregnancy, uteroplacental insufficiency, 
congenital anomalies especially renal abnormalities, meconium passage,  
fetal heart rate  abnormalities, low 5 minute  APGAR and increased 
NICU admission  are associated with Oligohydramnios4. Other studies 
are also shown that it is associated with increased   perinatal morbidity 
and mortality. Hence antepartum fetal surveillance is mandatory in 
pregnant women with Oligohydramnios. Hence Oligohydramnios in term 
is considered as an indication for termination of pregnancy. 
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Polyhydramnios is defined as AFI > 95th percentile for gestational 
age. More than fifty percent of women with polyhydramnios, the etiology 
was unknown. Congenital fetal anomalies accouts for 20%, among  which 
anencephaly occurs in 50% of the cases. Gestational diabetes, congenital 
infections also leads to the development of polyhydramnios. An increased 
risk of congenital abnormalities and perinatal mortality are associated 
with increasing severity of polyhydramnios5. Severe polyhydramnios 
(AFI ≥35 cm) is commonly associated with major congenital anomaly in 
31% of cases. 
So amniotic fluid volume assessment is an useful method to 
identify the fetus at risk for adverse obstetric and perinatal outcome. 
Therefore the present study was conducted to find out the perinatal and 
maternal outcome and to identify the possible causes of  abnormal liquor 
volume. 
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AIMS AND OBJECTIVES 
1. To study the obstetric outcome in pregnancies with 
oligohydramnios and polyhydramnios. 
2. To determine the perinatal outcome in pregnancies complicated 
with oligohydramnios and polyhydramnios. 
3. To determine the possible factors causing oligohydramnios and 
polyhydramnios 
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REVIEW OF LITERATURE 
AMNIOTIC FLUID 
Sources and Circulation: 
During the intrauterine development, the foetus is surrounded by 
the amniotic fluid . The precise site of origin of amniotic fluid is not well 
understood till now. Both maternal and foetal factors contributes to the 
development of liquor amnii6,7. It is produced from the sources listed 
below6,  
1. Transudation of maternal plasma across the amnion and chorion 
2. Transudation from foetal circulation through umbilical cord and 
placental membranes 
3. Transudation of foetal serum through the permeable foetal skin 
before keratinisation 
4. Secretion from the amniotic epithelium 
5. Foetal urine is the major source after 20 weeks of pregnancy  
6. Foetal lung fluid that enters amniotic cavity 
7. Secretions from foetal oral-nasal cavities also contributes to small 
extent 
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In first trimester inward transfer of solutes along with passive 
diffusion of water from extracellular fluid through the amnion and the 
permeable skin of the foetus is the likely source of amniotic fluid. After 
20th week, increasing stratification and cornification of the skin prevents 
diffusion, the foetal urine becomes the main source of amniotic fluid 
thereafter. During 4th- 5th weeks of gestation, foetal kidneys start to 
develop, by 8th to 11th weeks it begin to excrete urine and by 20thweek 
produces most of the amniotic fluid. Daily urine production depends upon 
the weight of the foetus, approximately 30% of foetal weight. The 
excreted urine via the amniotic fluid is recycled back to the foetus by 
swallowing, it is approximately 25% of foetal weight, hence it will not 
serve real excretory or homeostatic function. Therefore foetal urine 
output should be adequate to maintain amniotic fluid volume. An another 
important contributor of AFV is foetal lung fluid8. 
Brace9 et al 1997 described the factors involved in regulation of 
amniotic fluid volume,  
Flow out of the amniotic sac,  
1. Foetal swallowing ( 500-1000ml/ day) 
2. Intramembranous flow across the placenta and umbilical cord (200-
500 ml/day) 
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3. Transmembranous flow from amniotic cavity into the uterine 
circulation (10ml/day) 
Flow into the amniotic sac,  
1. Foetal urination (800-1200ml/day) 
2. Foetal lung liquid secretion (170ml/day) 
3. Oral-nasal secretions (25ml/day) 
Various conditions which affects these factors results in abnormal 
liquor volume during pregnancy.  
Volume of Amniotic Fluid8: 
Amount of AFV varies throughout the pregnancy. It increases from 
1ml at seven weeks to 25ml at ten weeks, 400ml at 20 weeks reaches 
about 1 litre at 36 weeks . Thereafter it decreases progressively to about 
800ml at term, as the pregnancy continues post term, further reduction 
occurs to the extent of 200ml at 42 weeks. 
Abhilash sandhyala and Radswiki et al studied the rate of change 
of amniotic fluid during each gestation. It raises from 10ml/ week at 8 
weeks to 25 ml/week at 13 weeks reaches a maximum at 21 weeks of 
about 60 mls/week and then decreases and reached 0 at 33 weeks. AFV 
decreases at rate of 8%/week after term. Fetal weight is corresponds with 
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AFV during the first half of pregnancy. Upto 30 weeks of gestation, ratio 
of amniotic fluid to fetal volume increase and then declines 
Queenan10 et al 1991 also described the correlation of AFV with 
fetal and placental weight in grams. 
Gestation age in 
weeks 
16 28 36 40 
Amniotic fluid in ml 200 1000 900 800 
Fetas weight in 
grams 
100 1000 2500 3300 
Placenta in grams 100 200 400 500 
 
Physical Features of Amniotic Fluid: 
Amniotic fluid is slightly alkaline in nature with pH of 7-7.5. 
Lower electrolyte concentration of fetal urine makes it hypotonic and it 
contains more urea, creatinine and uric acid compared to maternal serum. 
With increasing gestational age, fetal urine osmolality decreases. Specific 
gravity of liquor amnii is low6,7  
The colour of the amniotic fluid changes during the normal course 
of pregnancy. Before 20 weeks it ranges from a pale straw colour to deep 
yellow depending upon the amount of bilirubin. Before 20 weeks 
bilirubin is the normal constituent of amniotic fluid and does not indicate 
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the rhesus hemolytic disease in the fetus. After that the bilirubin 
concentration decreases. Normal amniotic fluid is colourless by 36 weeks 
of gestation. White floccules sometimes appear in the fluid during the last 
4-5 weeks due to the presence of desquamated fetal cells and free lipid 
material( vernix caseosa)6. 
Abnormal colouring usually results from contamination with 
meconium or blood, but it may also be due to bilirubin. High bilirubin 
levels after 30 weeks is considered as abnormal6. 
Chemical Composition of Amniotic Fluid6,7: 
The chemical composition of amniotic fluid is identical to maternal 
plasma in first half of pregnancy, as pregnancy advances it is changed 
markedly due to the addition of fetal urinary metabolites.  
The main content of amniotic fluid is water constitute 98.1-99%, 
the solid part forms the minor component of about 1-2 %. Solid 
component includes organic, inorganic and other suspended particles 
Organic Components: 
Protein -0.5mg,  
Non protein nitrogen-24mg 
Uric acid-4-5 mg,  
Sugar 19 mg,  
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Creatinne 2.2mg/ 100ml of amniotic fluid,  
Urea-30 mg,  
Total lipids- 50 mg,  
Bilirubin,  
Enzymes 
Hormones-Cortisone, human chorionic gonodotrophin, human 
placental lactogen, pregnanediol, 17-OH corticosteroids, estriol. 
Inorganic Components: 
Sodium, potassium, chloride and calcium. Sodium and chloride 
concentration decreases as pregnancy advances but potassium remains 
unchanged. 
Others:  
Cells from bladder, vagina and respiratory tract 
Vernix caseosa 
Exfoliated squamous epithelial cell from fetal skin and lanugo hair 
Amniotic cells 
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Evaluation of Amniotic Fluid: 
A diagnosis of an amniotic fluid abnormality may be suspected by 
physical examination like uterine fundal height & dates variation, but the 
diagnosis is generally made by the examination of the fluid compartments. 
Ultrasound evaluation is widely used technique among the various tests 
available to detect AFV. Being a non invasive method, makes it ideal for 
large scale use and repeat AFV determination in suspected amniotic fluid 
abnormalities. AFV by USG is done either by simple visual estimation or 
by biometric assessment. It is a semiquantitative method, never represent 
a true quantitative method11,12. 
Various methods used are,  
1. Dye dilution test13: It is considered as gold standard for assessment 
of amniotic fluid volume. However this is an invasive technique 
requiring amniocentesis and therefore not suitable for clinical 
practice which often needs repeated evaluation. In this technique a 
known volume of dye like aminohippurate sodium is injected into 
the amniotic cavity through amniocentesis. A sample of dye is 
taken after 20 mints which is analysed with spectrometry for 
degree of dilution. It reflects the actual AFV but invivo dye 
concentrations may undergo rapid changes. 
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2. Ultrasound evaluation of the amniotic fluid 
 Subjective method: It is based on the visualisation of AF 
pockets without measurements. The results are reported as either  
normal, low or high14. Examination by an experienced 
sonographer is necessary to reduce the intraobserver variation 
which is common in this method15.The results of this method is 
comparable with objective methods like AFI, SDVP, 2DP and 
dye dilution method. 
 Single deepest vertical pocket(SDVP): Manning et al 16in 1981 
described the concept of measuring the depth of maximum 
vertical pocket(MVP).They defined severe oligohydramnios as 
MVP <1cm, reduced liquor as MVP 1-2 cm.  
In 1984 chamberline et al16 defined the normal amount of 
amniotic fluid as the largest vertical pocket measuring 2-8cm, 
oligohydramnios as SDVP <2cm and polyhydramnios as SDVP 
>8 cm. While measuring SDVP ultrasound transducer probe 
should be right angle to the uterine contour without loops of cord 
structures and fetal parts. 
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 Amniotic fluid index (AFI): This method was proposed by 
phelan et al3 in 1987. It is a more objective and reproducible 
method as it estimates the amniotic fluid in four quadrants. The 
uterus is arbitrarily divided into four quadrants by the umbilicus 
transversely and linea nigra vertically. The deepest vertical 
pocket with no loops of cord and free of foetal parts in each 
quadrant is measured and it is summed up to give the AFI. 
Pockets are measured perpendicular to the floor with the patient 
in supine position. An AFI of 5-18 cm is considered normal, AFI 
of 18cm or greater is polyhydramnios or less than 5cm is 
oligohydramnios. Recently oligohydramnios has been defined as 
less than 3rd and 5th percentile and hydramnios more than 95th 
and 97th percentile for gestational age17. The reliability of 
correctly identifying oligo- or polyhydramnios using the 
percentiles is similar to SDVP(2-8) and AFI (5-18). 
 Two diameter pocket method (2-DP): It is an another semi 
quantitative method to assess the AFV which was described by 
magnan et al18 in 1992. He multiplied the depth of largest 
vertical pocket to its transverse diameter. According to this 
method normal AFV is 2-DP 15.1-50cm2, 2-DP <15cm2 defined 
as oligohydramnios and 2DP > 50cm2 defined as hydramnios.  
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Though the accuracy of ultrasound indices is good to diagnose 
normal amount liquor amnii, the sensitivity for both oligohydramnios and 
polyhydramnios remains poor19. All these measurements suffer from 
methodological limitations of two dimensional ultrasound and 
interference from foetal movements and loops of cord. 
 
Functions of Amniotic Fluid6,7: 
 Amniotic fluid acts as a shock absorber to protect the growing 
foetus from any external injury 
 Prevents adhesion formation between fetal parts and amniotic 
sac 
 Supplying nutrients  
 Facilitating growth and development of musculoskeletal system, 
lungs and gastrointestinal tracts 
 Promotes surfactant synthesis 
 Provides thermally stable environment 
 During labour it helps in dilatation of cervix by forming a wedge 
the bag of membranes  
 The amniotic fluid in the intact membranes prevents interference 
with placental circulation by preventing the umbilical cord 
compression during the uterine contraction. 
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 Antiseptic and bactericidal action of AF prevents ascending 
infection into the uterus 
Clinical Importance of Amniotic Fluid6,7:  
Amniocentesis has to be done to collect amniotic fluid for the 
following clinical purposes,  
 For the detection of developmental abnormalities and genetic 
diseases in the fetus 
 To assess the fetal lung maturity 
 To check fetal renal maturity 
 Hyaluronic acid which is rich in AF promotes bone healing 
 Prostaglandins and hypertonic saline are injected in the amniotic 
cavity for the induction of abortion 
 Artificial rupture of membranes is a one of the method for the 
induction and augmentation of labour 
 Detection of abnormal liquor volume either excess or low by 
AFI, helps in identifying a fetus at risk 
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POLYHYDRAMNIOS:  
Excessive amniotic fluid of more than 2000-2200ml is defined as 
polyhydramnios1,6,7. The incidence of polyhydramnios is 1%-2%, 
independant of race and ethinicity20. Multiparous  women has increased 
risk to develop polyhydramnios than primi. 
Definitions of hydramnios according to various study: 
Chamberlin et al21,22 SDVP > 8 cm 
Phelan et al3 AFI > 25 cm 
Carlson et al23 
AFI > 2SD of the mean for late 2nd 
and 3rd trimester (24cm) 
Moore et al17 
> 95th to 97th percentile for 
gestational age 
 
Classification:  
Based on the severity, Hill24, Biggio25 and Golan26 classified the 
polyhydramnios as mild, moderate and severe. Harman CR27  et al studied 
the perinatal mortality and anomalies associated with different types of 
polyhydramnios. 
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Types SDVP in cm AFI in cm % Perinatal Mortality in 1000 Anomalies(%) 
Mild  8-11 25-30  80  50  ≤ 6 
Moderate  12-15 30-35  15  190 ≤ 45 
Severe  >16  >35  5  540 ≤ 65 
 
Based on the onset, it is further classified as acute and 
chronic1,6. 
Acute polyhydramnios: it is a rare condition with acute onset and 
the accumulation of fluid within a few days. It often manifests before 20 
weeks, associated with monozygotic twins and chorioangioma of the 
placenta. Usually spontaneous abortion occurs, slow amnioreduction can 
be done for maternal distress. It often needs repeated amniocentesis. 
Chronic polyhydramnios: It is the most common type with gradual 
increase in fluid over few weeks. It usually occurs after 32 weeks. 
Causes of hydramnios: 
Polyhydramnios can be due to excessive production of liquor amnii 
or due to defective absorption. The degree of hydramnios as well as its 
prognosis is often related the cause. Both maternal and fetal causes leads 
to the development of polyhydramnios.  
  
18 
 
Its various causes are as follows: 
1. Idiopathic: In 66% of cases, cause is unknown 
2. Fetal causes:  
Congenital anomalies28 - 
 Anencephaly (50%) –It is a most common fetal 
congenital anomaly causing polyhydramnios. Increased 
urination caused by impaired ADH secretion, decreased 
swallowing reflex and increased transudation from the 
exposed meninges are the possible causes of hydramnios. 
 Open spina bifida- Increased transudation from the 
exposed meninges 
 Esophageal and duodenal atresia (15%) - Decreased 
swallowing of the liquor 
 Facial clefts and neck masses- by interfering with normal 
swallowing 
 Congenital diaphragmatic hernia 
 Fetal bartter syndrome 
 Fetal muscular dystrophy 
 Fetal sacrococcygeal teratoma 
 Fetal vein of galen aneurysm 
 Fetal infections 
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 Hydrops fetalis due to Rh isoimmunisation, 
cardiothoracic anomalies and fetal cirrhosis 
Multiple pregnancy due to large placenta- 10 times the 
incidence, It is more commmon in monoamniotic twins affecting 
the second sac 
  
3. Placental causes: 
 Placental chorioangioma due to increased transudation 
4. Maternal causes:  
 Diabetes (30%)- Due to fetal hyperglycemia causing fetal 
diuresis and hydramnios 
 Cardiac or renal diseases due to increased transudation 
from edematous placenta 
Clinical Presentation:  
Symptoms1,6,7: 
Depending upon the rapidity of its onset and degree of hydramnios, 
the clinical presentations will vary. Acute polyhydramnios will manifest 
like acute abdominal catastrophe like pain abdomen, nausea, vomiting. In 
gradual onset, the patient may present with increased abdominal girth, 
breathlessness on supine posture, digestive discomfort, swelling of the 
legs, varicosities in lower limb, occasionaly it can cause hyperemesis. 
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Mirror syndrome or ballantyne syndrome occurs in hydrops foetalis with 
hydramnios.  
Signs1,6,7: 
Dyspnoea on supine position 
Signs of preeclampsia –hypertension, albuminuria, edema. 
The foetus is freely ballottable 
Fluid thrill is present 
Foetal parts are difficult to palpate, foetal heart sounds are not 
easily audible 
Malpresentations are common 
Evaluation29: 
Ultrasonography : 
 It is helpful in the diagnosis of hydramnios 
 To exclude the other causes of hydramnios.  
 To detect associated congenital anomalies 
 To know the lie and presentation of the foetus 
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Blood Investigations: 
 Glucose tolerance test should be done to all women to exclude 
gestational diabetes. 
 Blood grouping and typing. If USG shows foetal hydrops, 
maternal antibody screen for D, C, Kell and Duffy antigen 
should be done to exclude alloimmunisation. Further 
evaluation for non immune hydrops can be done if antibody 
testing is negative. These include serology testing for syphilis, 
IgG and IgM for rubella, toxoplasma, parvovirus and 
cytomegalovirus. 
Invasive testing like amniocentesis can be performed for foetal 
karyotyping 
Differential Diagnosis6,7: 
1. Multiple pregnancy – it can be excluded from polyhydramnios 
by 1. Fundal height is more than the period of gestation 2. Too 
many foetal parts 3. Fluid thrill absent 4. USG will confirm 
the diagnosis  
2. Large ovarian cyst complicating pregnancy – 1. The gravid 
uterus is felt separately from the cyst 2. The cervix is pushed 
down into the pelvis but in hydramnios the cervix is drawn up 
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3. Maternal ascites- 1. Presence of shifting dullness 2. 
Resonance in the midline due to floating gut whereas in 
hydramnios it is dull 3.Size of the uterus will be normal  
4. Retoverted gravid uterus with full bladder  
5. Hydatiform mole 
6. Concealed abruption 
Complications1,6,7: 
Fetal Complications:  
Perinatal morbidity and mortality is increased in polyhydramnios. 
Most cases of mild hydramnios are idiopathic and carry a low risk for 
undiagnosed anomalies compared to severe hydramnios. Premature 
delivery and congenital anomalies are the main foctors responsible for 
morbidity and mortality. Other factors are cord prolapse, hydrops foetalis, 
operative delivery and abruption 
Maternal Complications: 
During Pregnancy: 
1. Abruptio placentae is most dreadly complication of 
hydramnios 
2. Gestatioal hypertension 
3. Abnormal foetal presentation 
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4. PROM 
5. Premature delivery either spontaneous or induced  
6. Cardio respiratory embarrassment 
 
During Labour: 
1. Increased incidence of cord prolapse 
2. Dysfunctional labour 
3. Uterine inertia 
4. Increased operative delivery 
5. Increased cesarean delivery 
6. Postpartum hemorrhage 
7. Retained placenta 
 
Postpartum Period: 
1. Subinvolution is common  
2. Puerperal sepsis due to increased operative interference and 
blood loss 
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Management : 
 Conservative Management with close observation 
will suffice in most of the cases of minor degree of 
Polyhydramnios 
 Moderate type of Polyhydramnios can be managed 
until labour starts.  
 Severe type often requires hospitalization, due to 
maternal respiratory distress, significant abdominal 
pain or premature uterine contractions. In this 
condition therapeutic amniocentesis is required.  
 Serial amnioreduction is required in conditions with 
fetal abnormality or twin-twin transfusion syndrome 
with severe polyhydramnios.  
 Amniocentesis: During amniocentesis 500 ml per 
hour (1500 to 2000ml per day) can be removed in 
single setting . Before the procedure placental 
localization should be done with ultra sound.  
25 
 
 Risks of Amniocentesis are fetal loss (1.2%), 
preterm labour, premature rupture of membranes, 
placental abruption, chorioamnionitis, Rh 
isoimmunisation and fetal pneumothorax.  
 Prostaglandin synthetase inhibitors: Among the PG 
synthetase inhibitors, indomethacin is the most 
commonly used drug. It reduces the amniotic fluid 
volume by decreasing the urine production from the 
fetal kidneys, decreasing the production of lung fluid 
and increased removal of fluid from the lungs as 
well as increased movement across fetal membranes. 
Dose is 1.4-3 mg/kg daily. (25mg 4-6 hourly to 75 
mg 12 hourly). Maternal side effects are GIT 
disturbances, rectal irritation, transient prenal 
insufficiency and cholestatic jaundice.   
 Sulindac is another prostaglandin inhibitor used in 
the treatment of polyhydramnios.  
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 If it is decided to induce labour, liquor should be 
drained carefully in a controlled manner, either by 
amniocentesis or by a needle inserted into the 
forewater to prevent cord prolapse and abruption. 
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OLIGOHYDRAMNIOS: 
Oligohydramnios is the condition in which the amount amniotic 
fluid is reduced to <200 ml at term. Incidence vary between 0.5 -  5%. 
Definitions based on USG measurements are,  
Manning16 et al  MVP < 1cm 
Chamberline 21,22et al  SDVP <2cm 
Phelan3 et al  AFI <5cm 
Jeng30 et al  AFI <8cm 
 
Conditions Associated with Oligohyadramnios1,6,29: 
Maternal Causes:  
1. Preterm premature rupture of membranes- 3-17 % 
2. Uteroplacental insufficiency 
3. Preeclampsia 
4. Postdated pregnancy 
5. Autoimmune disorders 
6. Drugs like ACE inhibitors, PG synthesis inhibitors 
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Fetal Causes: 
1. Chromosomal abnormalities- triploidy, turner syndrome, 
trisomy 18 - 4.4-30.7% 
2. Intrauterine growth restriction 
3. Intra uterine fetal demise 
4. Fetal infections 
5. Congenital anomalies- 7-37% 
Bilateral renal agenesis 
Multicystic dysplastic kidneys  
Bladder outflow tract obstruction 
Infantile polycystic kidney disease 
Musculoskeletal 
Cardiac 
Digestive  tract anomalies. 
Placental Causes: 
1. Abruptio placentae 
2. TTTS 
Idiopathic: Failure of secretion from amnion cells 
Clinical Implications1,26: 
Maternal outcome is not affected adversely due to oligohydramnios 
per se. However maternal morbidity is indirectly increased by higher rate 
of induction and cesarean deliveries. 
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Perinatal mortality and morbidity is significantly increased in 
oligohydramnios particularly if it occurs remote from term. Congenital 
anomalies, pulmonary hypoplasia, concurrent early onset of preeclampsia 
and IUGR are the main contributors to this adverse perinatal outcome. 
Recent studies and reviews suggests that isolated oligohydramnios in 
pregnancies with appropriately grown fetuses, reassuring fetal heart 
pattern and no maternal disease, does not increase the incidence of 
adverse perinatal outcome and therefore does not justify induction of 
labour. 
Diagnosis1,6,26:  
1. Uterine size is smaller than expected 
2. Decreased fetal movements 
3. Fetal parts are easily palpable 
4. USG is confirmatory 
Management 
It depends on 
1. Gestational Age 
2. Severity of  oligohydramnios 
3. Fetal status & well being 
4. Etiology 
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Treatment includes  adequate rest 
Hydration therapy – either oral or intravenous fluids (2 litres per days) to 
improve amniotic fluid volume. 
Amnioinfusion is done to prevent cord compression during labour & in 
case of meconium stained liquor to avoid meconium aspiration syndrome 
in the fetus. 
Induction of labour / LSCS  is based on fetal lung maturity, presence of 
congenital malformations, IUGR, severity of oligohydramnios. 
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MATERIALS AND METHODS: 
This descriptive study was carried out in the Department of 
Obstetrics and Gynaecology at Institute of Obstetrics and Gynaecology, 
Egmore, Chennai from October 2012 to September 2013, to evaluate the 
feto-maternal outcome in pregnancies complicated with abnormal liquor 
volume. Pregnant women with abnormal liquor volume who attended the 
antenatal clinic regularly and those who fulfilled the following criteria 
were included in this study as a study population. 
Cases were selected according to the following inclusion and 
exclusion criteria. 
Inclusion Criteria for Oligohydramnios: 
1. Singleton  pregnancy 
2.  Ultrasound finding of AFI ≤ 5cm 
3.  Gestational age of  28-42 weeks 
4. With intact membranes 
Exclusion Criteria for Oligohydramnios 
1. Intrauterine Fetal demise 
2. Prelabour rupture of membranes 
3. Post term pregnancy  
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Inclusion Criteria for Polyhydramnios: 
1.  Singleton pregnancy  
2.  Ultrasound finding of AFI ≥ 25cm 
3. Gestational age of  28 - 42weeks 
 Exclusion Criteria for polyhydramnios 
1. Multifetal gestation 
2.  Pregnancies before 28 weeks 
Approval from the Institutional Ethical Committee was sort. After 
getting the informed consent from the pregnant women who fulfilling the 
above criteria were taken up for the study.150 cases of Oligohydramnios 
and 50 cases of Polyhydramnios were selected as a study population. The 
study population were subjected to a detailed history taking including age 
of the patient, parity, last menstrual period, previous menstrual history, 
obstetric history, past medical and surgical history, family history, 
personal history were taken. Followed by complete physical examination 
including general examination (including Ht, Wt, BMI, BP recorded at 
each visit, presence of anemia and pedal edema), cardiovascular and 
respiratory systemic examination, obstetric examination were done. Base 
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line investigations like urine albumin, sugar& deposits, Hb%, OGCT, 
blood grouping and typing, HIV,VDRL, and HbsAg test were done.  
Obstetrical Ultrasound with Doppler was done for the study 
population using a real time scanner with 3.5-5MHz transducer by the 
same person to avoid the inter observer variation. Fetal presentation, 
gestational age, liquor status, placental localization, and anomalies if 
present were noted. Amniotic fluid index was measured by the Phelan’s 
technique. In this technique uterus was divided into four quadrants by an 
imaginary lines drawn through the linea nigra and the umbilicus. 
Maximum deepest vertical pocket from the each quadrant was measured. 
Sum total of the four measurement gives the value of AFI. Women with 
AFI of  ≥ 25 were taken as Polyhydramnios group and AFI  of ≤ 5 were 
taken as Oligohydramnios group. These women were closely monitored 
throughout their  antenatal, intrapartum and postpartum periods.  
 Age of the patient, distribution of parity, Gestational age at 
delivery, possible etiological factors causing abnormal liquor volume, 
rate of induction, liquor colour, No of vaginal, cesarean and instrumental 
deliveries, indications for the cesarean section, intrapartum complications 
like cord prolapse, preterm labour, PROM, malpresentation, abruptio 
placentae, immediate postpartum complications like atonic PPH, retained 
placenta were noted. Fetal outcome, five minutes apgar, birth weight,  
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Neonatal Intensive Care Unit (NICU) admission, perinatal morbidity and 
mortality were also noted. All these datas were entered in the preformed 
proforma and these different variables were tabulated and analyzed by 
SPSS 11.5. 
STATISTICAL METHODS: 
T test, chi square and fisher test were used for the statistical 
analysis. Critical value at 0.05 was considered as a significant level. 
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OBSERVATION AND RESULTS
                                                 
AGE DISTRIBUTION IN ABNORMAL LIQUOR VOLUME
This table shows, the age distribution in the study population. Among the 
150 oligohydramnios group, 57.3% were in the age of 20
the 50 polyhydramnios group, 42% were in the age of 26
 
AGE IN 
YEARS 
AFI 
NO OF 
CASES 
N-150 
≤19 12 
20 -25 86 
26 – 30 42 
31 -35 8 
above 35 2 
35 
-25 26 – 30 31 -35 above 35
57.3
28
5.3
1.3
34
42
8 10
Age in years
AFI ≤5
AFI ≥25
 
TABLE-1  
 
-25 yrs. Among 
-30 yrs.  
CHART 1 
GROUP 
≤5 AFI ≥25 
% 
NO OF 
CASES 
N-50 
%
8.0 3 
57.3 17 34
28.0 21 42
5.3 4 
1.3 5 10.0
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PARITY DISTRIBUTION IN ABNORMAL LIQUOR VOLUME
OBSTETRIC 
SCORE NO OF 
CASES
N-150
Primi 99 
G2 – 3 51 
G4 -5  0 
This table shows the parity distribution in abnormal liquor volume. 66% 
of the cases in oligohydramnios group were 
56%  were multigravida in polyhydramnios group.
 
36 
G2 – 3 G4 -5 
34
0
56
12
Obstetric Score
Volume
AFI ≤ 5
AFI  ≥ 25
TABLE -2 
GROUP 
AFI ≤ 5 AFI  ≥ 25 
 
 
% 
NO OF 
CASES 
N-50 
66 16 
34 28 
0 6 
primigravida, compared to  
 
CHART 2 
 
 
% 
32 
56 
12 
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                                                  TABLE-3 
GESTATIONAL  AGE AT DELIVERY IN ABNORMAL LIQUOR 
VOLUME 
 GROUP 
 AFI ≤ 5 AFI ≥ 25 
GESTATIONAL 
AGE IN 
WEEKS 
NO OF 
CASES % 
NO OF 
CASES % 
28 -32 weeks 12 8 7 14 
33 -37 weeks 44 29.33 11 22 
>37 weeks 94 62.66 32 64 
 
This table shows, the gestation age at delivery in the study population. In 
oligohydramnios group, 62.66% were in the gestation age of >37 weeks, 
29.33% between 33-37 weeks and 8% between 28-32 weeks. In the 
polyhydramnios group also, 64% were in >37 weeks, 22% between 33-37 
weeks, 14% between 28-32 weeks. According to this table, incidence of 
term and preterm delivery in abnormal liquor volume is not statistically 
significant with p value 0.338. 
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CHART 3 
33 -37 >37 
29.33
62.66
22
64
Volume
AFI ≤ 5
AFI ≥ 25
 
 Maternal Conditions Associated with 
Postdated pregnancy
MATERNAL CONDITIONS ASSOCIATED WITH 
OLIGOHYDRAMNIOS
MATERNAL 
CONDITIONS 
Postdated pregnancy 
Hypertensive Diseases 
Anemia 
APLA 
  
This table shows maternal conditions associated with oligohydramnios in 
which 28.67% were postdated pregnancy, 17.34% hypertensive disease
(among which 15.38% were gestational hypertension, 84.61% were 
preeclampsia), 3.33% of anemia 
present. 
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28.67%17.34%
3.33%
1.33%
Oligohydramnios
Hypertensive Diseases Anemia APLA
TABLE-4 
 
AFI≤ 5 
NO OF CASES 
N-150 
% 
43 28.67 
26 17.34 
5 3.33 
2 1.33 
and 1.33%  of APLA syndrome were 
CHART 4 
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TABLE-5 
MATERNAL CONDITIONS ASSOCIATED WITH 
POLYHYDRAMNIOS 
MATERNAL 
CONDITIONS 
         AFI ≥ 25 
     NO OF CASES 
              N- 50 
% 
GDM 8 16 
Gestational Hypertension 2 4 
Preeclampsia 3 6 
Rh Negative 1 2 
Chorioangioma of Placenta 1 2 
 
 GDM NO. OF CASES 
N-60 
% 
Controlled  5 62.5 
Uncontrolled GDM 3 37.5 
 
 This table shows the polyhydramnios associated maternal 
conditions.Among the 50 cases, GDM were present in 16% (out of which 
62.5% were controlled GDM, 37.5% were uncontrolled), Preeclampsia in  
6%, gestational hypertension in 4%, Rh negative pregnancy in 2% and 
chorioangioma of the placenta in 2%.     
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CONGENITAL ANOMALIES ASSOCIATED WITH
OLIGOHYDRAMNIOS
CONGENITAL 
ANOMALIES 
Multicystic dysplastic kidney
Infantile PCKD 
Single umblical artery 
Micro cephaly 
In 50 oligohydramnios patients, only 4% had congenital anomalies. 
Among which infantile 
Single umbilical artery 0.67%, microcephaly 0.67%.
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Infantile 
PCKD
Single 
umblical 
artery
Micro 
cephaly
2
0.67 0.67
Oligohydramnious
TABLE -6 
 
AFI ≤ 5 
NO OF CASES 
N-6 
% 
 1 0.67 
3 2.0 
1 0.67 
1 0.67 
polycystic kidney disease 2%, MCKD 0.67%, 
 
CHART 6 
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TABLE-7 
CONGENITAL  ANOMALIES ASSOCIATED WITH 
POLYHYDRAMNIOS 
CONGENITAL 
ANOMALIES 
AFI ≥ 25 
NO OF CASES 
              N-11 
% 
Anencaphaly 4 8 
Diaphragmatic Hernia 1 2 
Duodenal atresia 1 2 
Non Immnue Hydrops 1 2 
Spinabifida 2 4 
Hydrocephalus with 
meningomyelocele 2 4 
 
In 50 polyhydramnios cases, Total of 22% had congenital anomalies. 
Among which anencephaly was the common anomaly accounts 8% , 
spina bifida 4%, hydrocephalus with meningomyelocele 4%, 
Diaphragmatic hernia 2%, Duodenal atresia 2% and Non immune 
hydrops in 2% . 
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TABLE -8 
ETIOLOGICAL FACTORS IN OLIGOHYDRAMNIOS 
ETIOLOGY 
AFI ≤ 5 
NO OF CASES 
N-150 
% 
Postdated Pregnancy  43 28.67 
IUGR 19 12.66 
Hypertensive Diseases 26 17.34 
Congenital Anomalies 6 4.00 
Idiopathic  56 37.33 
 
This table shows the etiological factors in oligohydramnios group. 
According to this table 37.33% were isolated oligohydramnios with no 
identifiable cause, 28.67%  were  post dated pregnancy, 12.66%  were 
IUGR,  17.34%  were  hypertensive diseases, 4%  were congenital 
anomalies. 
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CHART 8 
 
IUGR Hypertensive 
Diseases
Congenital 
Anomalies
Idiopathic 
12.66
17.34
4
37.33
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TABLE -9 
ETIOLOGICAL FACTORS IN POLYHYDRAMNIOS 
ETIOLOGY 
AFI ≥ 25 
NO OF CASES 
N-50 
% 
Idiopathic 29 58 
Congenital Anomalies 11 22 
GDM 8 16 
Rh- Isoimmunisation 1 2 
Chorioangioma of the placenta 1 2 
 
This table shows the various etiological factors causing  polyhydramnios 
in the study population. Exact cause of polyhydramnios  were  not 
detected in 58% of the cases. 22% had congenital anomalies, 16%  had 
GDM, 2% had Rh isoimmunisation  and  2% chorioangioma of the 
placenta. 
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 18%
6%
Severity of Polyhydramnios
SEVERITY OF POLYHYDRAMNIOS
TYPES (AFI) 
Mild (25-30) 
Moderate (31-35) 
Severe (>35) 
 
This table shows the severity of polyhydramnios.
polyhydramnios, 18% were moderate and 
polyhydramnios group. 
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76%
Mild (AFI 25-30)
Moderate (AFI 31-35)
Severe (AFI >35)
TABLE -10 
 
NO OF CASES 
N-50 
% 
38 76 
9 18 
3 6 
 76% were in mild 
6% were in severe 
CHART 10 
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       ONSET OF LABOUR IN ABNORMAL LIQUOR VOLUME
ONSET OF 
LABOUR 
N- 150
Spontaneous 52
Induced         98
 
This table shows the onset of labour in abnormal liquor volume. Among 
the oligohydramnios group, 65.33% were induced compared to 20% in 
polyhydramnios group, which was highly significant with p value of 
0.0001. 
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TABLE -11 
GROUP 
AFI ≤ 5 AFI ≥ 25 
 % N-50 %
 34.67 40 80
 65.33 10 20
CHART 11 
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                                     TABLE-12 
                                MODE OF DELIVERY 
 
 
MODE OF 
DELIVERY 
GROUP 
AFI   AFI ≥ 25 
N- 150 % N-50 % 
SPVD 45 34 36 72 
Instrumental delivery 10 6.66 5 10 
cesarean 89 59.33 9 18 
 
 
This table shows mode of delivery in abnormal liquor volume. In 
oligohydramnios group 59.33% were underwent cesarean section 
compared 18% in  polyhydramnios group which is statistically significant 
with p value of 0.000. In polyhydramnios group 82% delivered vaginally 
compared to 40.66% in oligohydramnios group which is also statistically 
significant. 
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                                              TABLE-13 
INDICATIONS OF CESAREAN SECTION 
 
 
Among the indications for cesarean section in abnormal liquor volume, 
76.40% were due to fetal distress, 11.23% due to CPD,  8.98% due to 
failed induction,  3.37% due to malpresentation in oligohydramnios group. 
In polyhydramnios group, 33.33% were due to CPD, 22.22% were due to 
malpresentation and fetal distress, 11.11% were due to cord prolapsed 
and failed induction. 
 
  
INDICATIONS 
GROUP 
AFI ≤ 5 AFI ≥ 25 
N-89 % N-9 % 
Fetal Distress 68 76.40 2 22.22 
CPD 10 11.23 3 33.33 
Failed Induction 8 8.98 1 11.11 
Mal presentation 3 3.37 2 22.22 
Cord Prolapse - - 1 11.11 
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COLOUR OF LIQUOR IN ABNORMAL LIQUOR VOLUME
COLOUR OF 
LIQUOR 
Clear 
Meconium 
This table shows the colour of 
had meconium stained liquor
in polyhydramnios group, which is statist
0.000. 
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 5 AFI ≥ 25
88
12
Meconium
Clear
TABLE -14 
 
GROUP 
AFI ≤ 5 AFI ≥ 25 
N- 150 % N-50 %
64 42.66 44 88
86 57.33 6 12
 
 liquor in Abnormal liquor volume
 in oligohydramnios group compared to 12% 
ically significant with p value 
CHART 14 
 
 
 
 
. 57.33% 
 4%
2%
14%
Labour Complications in Abnormal Liquor 
LABOUR COMPLICATIONS IN POLYHYDRAMNIOS
LABOUR 
COMPLICATIONS 
PROM 
Cord Prolapse 
Atonic PPH 
Retained Placenta 
Preterm Labour 
 
This table shows intrapartum and postpartum
Polyhydramnios cases. A
labour, 6% Cord Prolapse, 4% Atonic PPH, 2% Retained Placenta.
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TABLE - 15 
AFI ≥ 25 
NO OF CASES 
N-50 
% 
10 20 
3 6 
2 4 
1 2 
7 14 
 complications in 
mong which 20% were PROM , 14% Preterm 
CHART - 15 
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TABLE -16 
FETAL OUTCOME IN ABNORMAL LIQUOR VOLUME 
FETAL OUTCOME 
GROUP 
AFI   AFI ≥ 25 
N- 150 % N-50 % 
Alive 139 92.7 36 72 
Perinatal Death 11 7.3 14 28 
 
 
This table shows Fetal Outcome in pregnancies with  Abnormal Liquor 
Volume.  In Oligohydramnios group 92.70% were alive compared to 72% 
in polyhydramnios group. Perinatal death was 28% in polyhydramnios 
group compared to 7.3% in oligohydramnios group which is statistically 
significant  p value of 0.0001. 
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TABLE -17 
5 MINUTES APGAR IN ABNORMAL LIQUOR VOLUME 
5 MINUTES APGAR 
GROUP 
AFI   AFI ≥ 25 
N- 150 % N-39 % 
<7 58 38.66 11 28.20 
≥7 92 61.33 28 71.79 
 
This table shows the 5 minutes apgar status in abnormal liquor volume. 5 
minutes apgar score in oligohydramnios group was  <7 in 38.66% 
compared to 28.20% in polyhydramnios group which is not statistically 
significant.  
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TABLE -18 
BIRTH WEIGHT IN ABNORMAL LIQUOR VOLUME 
BIRTH WEIGHT IN 
kg 
GROUP 
AFI   AFI ≥ 25 
N- 150 % N-39 % 
≤ 2.5 81 54 6 15.38 
2.6-3 45 30 10 25.64 
3.1-3.5 19 12.66 15 38.46 
3.6-4 5 3.33 5 12.82 
> 4 - - 3 7.69 
 
This table shows the birth weight distribution in abnormal liquor 
volume.In oligohydramnios group, 54% were  ≤ 2.5 kg, 45.99% were 
between 2.6-4 kg, no babies were born above 4 kg. In contrast 
polyhydramnios group delivered 76.92% babies with birth weight 
between 2.6-4 kg, 7.69% with >4 kg and 15.38% with ≤2.5kg.   
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AFI ≥ 5
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TABLE -19 
IUGR IN ABNORMAL LIQUOR VOLUME 
 
GROUP 
AFI   AFI ≥ 25 
N- 150 % N-50 % 
IUGR 28 18.66 - - 
 
According to this table, 18.66% of babies were IUGR in oligohydramnios 
group. No cases of IUGR was present in polyhydramnios group. 
 
  
 NICU ADMISSION IN ABNORMAL VOLUME
 
NICU Admission 
This table shows the N
volume. Compared to polyhydramnios group 
admitted in NICU in oligohydramnios 
significant with p value of 0.0001.
 
    
28 %
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TABLE -20 
 
GROUP 
AFI ≤ 5 AFI ≥ 25 
N- 150 % N-39 %
76 50.66 14 28
 
umber of NICU admission in abnormal
, 50.66% of  babies were 
group which is statistically 
 
 
50.66 %
NICU Admission
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AFI ≥ 25
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DISCUSSION 
Various studies have been presented to know the perinatal 
morbidity and mortality in pregnancy with abnormal liquor volume. In 
the same way our study was tried to reveal the fetomaternal outcome in 
abnormal liquor volume in our Institute of Obstetrics and Gynaecology, 
Egmore, Chennai. 
In our study, 57.3% were in the age of 20-25 yrs in 
oligohydramnios group, 42% were in the age of 26-30 yrs in 
polyhydramnios group. This is comparable  to Guin et al4 study in 2011 
In our study, among the parity distribution, 66% of the cases in 
oligohydramnios group were primigravida, but  there was no significant 
relation of age and parity with oligohydramnios according to the study  
done by Casey et a31,  Chauhan et al32,33, Magann et al15. In  
polyhydramnios group majority of the women were multigravida which is 
comparable to study by Guin et al4 . 
 In our study, majority of the women in the gestation age of  >37 
weeks in both oligo and polyhydramnios group. 
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Maternal conditions associated with abnormal liquor volume: 
Oligohydramnios: 
 In our study, 28.67% were postdated pregnancy as compared to 
10.7% in Guin et al4 study. 
In our study, 17.34% were hypertensive disease of pregnancy as 
compared to 38.46% in  Chandra et al34 study, 3.5% in Guin et al4  study 
and 8% in Preshit et al35 study. 
In our study, anemia were  present in 3.33% of cases. APLA were 
present in 1.33%. 
Polyhydramnios: 
In our study, GDM were present in 16%  as compared to Guin et 
al4  study where 20% cases  were GDM  and 5%  cases were GDM in 
Vaid et al36 study. 
In our study, 10%  cases were hypertensive diseases as compared 
to 17.7% in Guin et al4 study and 13% in Vaid et al36 study. 
In our study, 2%  cases  were Rh negative pregnancy as compared 
to Guin et al4 where Rh -ve  pregnancy were 4.4% , 1% in Lyndon M Hill 
et al37 study. 
In our study, 2% cases  were chorioangioma of the placenta  
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Congenital anomalies in abnormal liquor volume: 
Oligohydramnios  
In our study, total of  4% cases had  congenital anomalies as 
compared to 12.9% in Guin et al study, 5.8% in Anil Shetty et al38. 
In our study, infantile PCKD were 2%  as compared to Guin et al4 
study where 7.5% were PCKD. In our study 0.67% were MCKD, single 
umbilical artery and microcephaly. 
Polyhydramnios. 
In our study, total of 22% had congenital anomalies which was 
comparable to Guin et al4 study where 31.1% were associated with 
congenital anomalies. 
 In our study, anencephaly was the common anomaly that account 
for 8% as compared to 6% in Guin et al4 study and  65.96% in Vaid et 
al36 study. 
Spina bifida were present in 4% cases in our study  as compared to 
4% in Guin et al4 study. 
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Hydrocephalus with meningomyelocele were in 4% cases in our 
study as compared to Guin et al4 study where  10% cases  were 
hydrocephalus, 10.63% in Vaid36 et al study. 
Diaphragmatic hernia were present in 2% in our study, Duodenal 
atresia were 2% in our study as compared 4% in Guin et al4 study. 
In our study, Non immune hydrops were present in  2% cases as 
compared to  7% in Nicole Damato et al39  study. 
Etiological factors in abnormal liquor volume: 
Oligohydramnios 
In our study, 37.33% were isolated oligohydramnios with no 
identifiable cause as compared to 52% in Krishna jagatia et al.  
In our study, 28.67% were postdated pregnancy as compared to 
10.7% in Guin et al4 study.  
In our study, 17.34% were hypertensive disease of pregnancy as 
compared to 38.46% in  Chandra et al34 study, 3.5% in Guin et al4  study 
and 8% in Preshit chate et al35 study. 
In our study, 12.66%  cases were IUGR which was comparable 
with Guin et al4 study of 14.2%  and  25% in Anil Shetty et al38 study.  
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In our study,  4% cases were  congenital anomalies as compared to 
12.9% in Guin et al4 study, 5.8% in Anil Shetty et al38 study. 
Polyhydramnios: 
In our study, exact cause of polyhydramnios  were not detected in 
58% which is comparable with Brady et al40 study.  
In our study, total of 22% had congenital anomalies which was 
comparable to Guin et al4 study where 31.1% were associated with 
congenital anomalies. 
16%  had GDM in our study which was comparable to 20% in 
Guin et al4 study. 
In our study, 2% had Rh isoimmunisation as compared to 4.4% in 
Guin et al4 study, 1% in Lyndom M Hill et al27. 
 In our study, chorioangioma of the placenta were present in 2% of 
cases. 
Severity of polyhydramnios: 
In our study , 76%, 18%, 6% patients were mild, moderate and 
severe polyhydramnios respectively, which was comparable to Lyndon M. 
Hill et al37 where 77.4%, 18.6%, 4% were mild ,moderate and severe 
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polyhydramnios respectively. Majority of mild polyhydramnios were 
detected at term in our study. 
In our study, induction rate was higher in oligohydramnios group 
of about 65.33% as compared to Guin et al4 where 56.5% cases were 
induced.  
In polyhydramnios group only 20% cases were induced as 
compared to 13.6% in Guin et al4 study. 
The rate of cesarean section was 59.33% in oligohydramnios group 
which is comparable to  42.8% in Guin et al4 study, 64% in  
Preshit chate et al35 and 76.92% in Chandra P et al34 study. This increased 
rate of cesarean was due to  fetal distress. In our study 76.4% cases had 
fetal distress which in turn due to increased meconium stained liquor 
( 57.33%) and IUGR. (18.66%) in our study. 
In our study, 38.66% of babies had low 5 minute APGAR score in 
oligohydramnios group  as compared to  23.7% in Chandra et al34, 16% in 
Preshit chate et al35. 
In polyhydramnios group only 18% underwent cesarean section as 
compared to 22.2% in Guin et al4 . Instrumental delivery rate was not 
significant in both oligo and polyhydramnios group in our study. 
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In our study, with polyhydramnios group, 20% cases were PROM 
as compared to 44.5% in Guin et al4, 14% were preterm labour which was 
comparable to 40% in Guin et al4,   6% had  cord prolapse as compared to 
4.4% in Guin et al4 study. 
 In our study, atonic PPH were occurred in 4% of cases as 
compared to 4.4% in Guin et al4 study. Retained placenta were seen in 2% 
cases in our study. 
In our study, polyhydramnios group had high perinatal mortality 
rate of 28% as compared to oligohydramnios group which is 7.3%. This 
was  comparable with Guin et al4 study where perinatal mortality  were 
42.25% in polyhydramnios and 12.9% in oligohydramnios group. This 
high perinatal mortality in polyhydramnios group  was due to increased 
fatal congenital anomalies. 
In our study, with  oligohydramnios group, 54% were  ≤ 2.5 kg as 
compared to Chandra et al34 and Preshit Chate et al35, 45.99% were 
between 2.6-4 kg, No babies were born above 4 kg.   
In contrast polyhydramnios group delivered 76.92% babies with 
birth weight between 2.6-4 kg, 7.69% with >4 kg and 15.38% with 
≤2.5kg  in our study. 
71 
 
In our study, 50.66%  babies were admitted in NICU in 
oligohydramnios group which is comparable to  46.15% in  
Chandra et al34  and 42% in Preshit Chate et al36 study. In 
polyhydramnios group 28% of  babies were admitted in NICU. 
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SUMMARY 
1. Majority of the oligohydramnios cases were primigavida and 
polyhydramnios cases were multigravida. 
2. Most of the patients with abnormal liquor volume were diagnosed 
at term. 
3. Mild polyhydramnios was the most common type. 
4. Isolated oligohydramnios (37.33%)  was the most common cause 
followed by post dated pregnancy (28.67%) and third being the 
hypertensive diseases of pregnancy( 17.34%)  in oligohydramnios 
group. 
5. Idiopathic polyhydramnios (58%) were the first common cause of 
polyhydramnios, the second were congenital anomalies( 22%) and 
the GDM (16%)  was the third one . 
6. Incidence of congenital anomalies were high in polyhydramnios 
(22%) than in oligohydramnios (4%). 
7. Most common congenital anomaly in oligohydramnios group were 
Infantile polycystic kidney disease. In polyhydramnios group, 
anencephaly was the most common anomaly followed by spina 
bifida, hydrocephalus with meningomyelocele. 
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8. Induction of labour was high in oligohydramnios group (65.33%) 
than  in polyhydramios  (20%) group. 
9. 59.33% were underwent cesarean section  in oligohydramnios 
group compared to 18% in polyhydramnios group. 
10.  Fetal distress (76.4%)  was  the leading cause of cesarean in 
oligohydramnios , CPD (33.33%) was the common cause in 
polyhydramnios group. 
11. There is No significant difference in instrumental delivery in both 
groups 
12. Meconium stained liquor were common in oligohydramnios 
group. 
13. In polyhydramnios group, the major labour  complications  were 
PROM and preterm labour. 
14. No maternal mortality was present in our study. 
15. In oligohydramnios group, the alive babies rate were 92.7% and 
perinatal death was 7.3%. In polyhydramnios group, the alive and 
perinatal death rate were 72%, and  28% respectively. 
16. In the oligohydramnios group, congenital anomaly was not the 
cause of any perinatal death but in polyhydramnios group majority 
of the death were due to lethal congenital anomalies. 
17.  Birth weight <2.5 kg  were high in oligohydramnios group (54%). 
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18.  IUGR cases were common in oligohydramnios group. 
19. NICU admission was highest  in oligohydramnios group (50.66%) 
than polyhydramnios ( 28%)group. 
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CONCLUSION 
 Development of abnormal liquor volume during pregnancy signals 
danger to the foetus. It  is associated with an increased incidence of 
caesarean section,  labour  complications and  adverse  perinatal 
outcome. 
  But isolated oligo and polyhydramnios in term gestation has better 
perinatal outcome compared to early onset and with associated  
conditions like hypertensive diseases of pregnancy, GDM, IUGR. 
 Ultrasound is the ideal method to detect any abnormality in liquor 
volume. If any abnormality is detected during the ultrasound, a 
careful search should be made to detect any identifiable congenital 
anomalies. 
 A detailed history, clinical examination  and relevant investigations 
should be done to identify the various   etiological factors in all 
cases of abnormal liquor volume, to get better  foetal outcome as 
well as to avoid  the maternal complications. 
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PROFORMA 
 
NAME:                               AGE:                              IP NO: 
UNIT: 
ADDRESS:                                                                DOA: 
SOCIO ECONOMIC STATUS: 
BOOKED/UNBOOKED:        
LMP: 
EDD: 
OBSTETRIC FORMULA :                   G         P        L         A 
PRESENTING  COMPLAINTS: 
H/O Amenorrhea 
H/O Bleeding pv/ Draining pv 
H/O Perception of fetal movements. 
 PRESENT OBSTETRIC HISTORY:  
 
 PAST OBSTETRIC HISTORY :  
 
MENSTRUAL HISTORY: 
        Age at Menarche: 
Menstrual Cycles: 
MARITAL HISTORY: 
Married Since: 
 Consanguineous/ Non Consanguineous 
  
  
PAST HISTORY:  
History of  DM / HT / TB / Rheumatic  Heart Disease / Epilepsy /  
Thyroid / Bronchial asthma 
 
FAMILY HISTORY: 
 
PERSONAL HISTORY:      Diet, Sleep, Bladder & Bowel habits 
      
GENERAL EXAMINATION: 
HT:    WT:  BMI: 
TEMP:  BP:   PR:    RR: 
PALLOR / ICTERUS / PEDAL EDEMA 
CVS:      BREAST: 
RS:      THYROID: 
  PER ABDOMEN: 
   Size of Uterus (In Weeks): 
 Acting/Not Acting: 
 Presenting Part: 
 Engaged/ Unengaged: 
 FHR: 
 Amount of liquor  
  
PER VAGINAL EXAMINATION: 
INVESTIGATIONS: 
• URINE INVESTIGATIONS: 
           Urine albumin:  Sugar:           Deposits: 
• BLOOD INVESTIGATIONS: 
Blood grouping and typing 
HIV & VDRL 
HB%                
          Random blood sugar 
          OGCT 
          Admission CTG 
ULTRASOUND  OBSTETRICS WITH DOPPLER: 
 Presentation  
 GA 
 Placenta 
 AFI  
 Congenital Anomalies if any 
DETAILS OF DELIVERY: 
Mode of delivery: Spontaneous/ Induced 
Labour  natural: 
Operative vaginal Delivery : Vaccum  /  Forceps 
                                                                  Indication  
          LSCS :  Indication  
LIQUOR :  Scanty  / Average   / Excess  
   Meconium Stained  /  Clear  
 
RU LU 
RL 
   LL 
  
BABY DETAILS : 
Live / still born  
Term / Preterm / IUGR /SGA / LGA 
  Date and time of birth 
  Birth weight  
           Apgar  
  Any congenital anomalies  
NICU Admission: Yes  /   No 
Cause for admission 
                     No of days in NICU 
Iv antibiotics: Yes  /  No 
CXR:    Yes  / No 
PERINATAL MORTALITY  ( if  any ): 
NEONATAL OUTCOME:      Healthy / Neonatal death 
COMPLICATIONS DURING DELIVERY: 
MATERNAL : 
  Uterine inertia  
  APH 
  PPH  
  Preterm labour  
  PROM 
Cord prolapse  
 
  
  
  
  
PATIENT CONSENT FORM 
Title of the Project 
A CLINICAL STUDY OF FETO-MATERNAL OUTCOME IN  PREGNANCIES 
WITH ABNORMAL LIQUOR VOLUME 
Institution  : INSTITUTE OF OBSTETRICS & GYNAECOLOGY, 
    Egmore, Chennai-600008. 
 
Name :       Date : 
 
Age :       IP No. : 
 
Sex :       Project Patient No. : 
 
The details of the study have been provided to me in writing and explained to me in 
my own language. 
I confirm that I have understood the above study and had the opportunity to ask 
questions. 
I understood that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without the medical care that will normally 
be provided by the hospital being affected. 
I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s). 
I have been given an information sheet giving details of the study. 
I fully consent to participate in the above study regarding abnormal liquor volume 
____________________  ____________________ 
 ____________ 
    Name of the subject   Signature         Date 
  
INFORMATION TO PARTICIPANTS 
 
Title :  A CLINICAL STUDY OF FETO-MATERNAL OUTCOME IN  
  PREGNANCIES WITH ABNORMAL LIQUOR VOLUME 
 
Principal Investigator : Dr.PUNITHAVATHI.J 
Name of Participant : 
Site    : Institute of obstetrics and gynaecology 
You are invited to take part in this study. The information in this 
document is meant to help you decide whether or not to take part. Please 
feel free to ask if you have any queries or concerns. 
WHAT IS THE PURPOSE OF RESEARCH? 
An increased (or) decreased liquor volume, in pregnancies between 28-42 
weeks of gestation, is associated with an increased incidence of 
complication in labour, cesarean section and adverse perinatal outcome. 
The purpose of this study is to evaluate the obstetrics outcome and to find 
the cause wherever is possible in pregnancies with abnormal liquor 
volume. 
THE STUDY DESIGN 
Pregnant women admitted at IOG, Egmore with abnormal liquor volume 
(Oligohydromnios or polyhydromnios) or diagnosed during their stay at 
IOG are followedup and their pregnancy outcome evaluated. They are 
subjected to Ultrasound Examination and necessary routine investigations 
are done. 
STUDY PROCEDURES 
  
Pregnant women with gestational age between 28-42 weeks with 
abnormal liquor volume are subjected to ultrasound examination. 
Necessary routine investigations are done to find the cause. The effect of 
abnormal liquor volume in labour (increased incidence of caesarian 
section, instrumental deliveries) and perinatal outcome is evaluated. 
Possible risks to you – Nil 
Possible benefits to you - you will be under regular follow up till 
discharge. 
Possible benefits to other people 
 The results of the research may provide information regarding the 
factors associated with abnormal liquor volume and we can limit the 
serious maternal and fetal complication. 
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1 Lavanya 25 28074 Primi 38 Anemia 4   Idiopathic I C  OUTLET      A/T AGA >7 3.2     
2 Vijayalakshmi 22 27999 G2A1 38 PE 3.2   PE S C CS FD   A/T/SGA <7 2.9 AD   
3 Selvi 31 28096 G3P2L2 30   3   Idiopathic I M VD     A/PT/SGA >7 2.4 AD   
4 Chandrakala 21 27200 G2P1L1 40+2 4.2   PD I C OUTLET     A/T/AGA >7 3.4     
5 Saranya 20 26344 Primi 32 GHT 5   GHT S C VD     A/PT/AGA <7 1.9 AD   
6 Chitrapriya 
24 
27976 G2P1L1 39 
 
 
4   Idiopathic S C VACCUM     A/T/SGA <7 2.49 AD   
7 Yasmin fathima 21 28119 primi 35 
 
 
3.4   Idiopathic I M CS FD   A/PT/AGA >7 2.4     
8 sangeetha 28 28111 primi 31 
 
 
NIL B/L MCKD Anomaly I M VD     A/PTSGA <7 1.4 AD D 
9 Sreelekha 29 28891 Primi 36   4.9   Idiopathic S M VD     A/PT/SGA <7 2.51     
10 Nandhini 23 28901 Primi 40+1 5   PD I C CS FI   A/T/SGA <7 2.6     
11 suganya 19 28890 primi 31   2   Idiopathic I M VD     A/PT/AGA <7 1.2 AD D 
12 Saranya 25 28702 G3P1L1A1 40+3 3.6   PD I C CS FI   A/T/AGA >7 3.17     
13 Padmavathi 28 27202 primi 40+2   2   PD I M VD FD   A/PT/AGA <7 2.45 AD   
  
14 Sharmila 24 29920 G1P1L1 32 4.8   Idiopathic I M CS FD   A//T/AGA <7 1.2 AD   
15 Fradeena robinson 21 23360 Primi 29 PE 1.9   PE I C VD     A/PT/AGA >7 1.1 AD   
16 Sudha 20 28101 Primi 40+2 3.7   PD S C CS FI   A/T/SGA <7 2.6     
17 Devika 23 29792 G3A2 37   5   Idiopathic S C VD FI   A/T/SGA >7 2.54     
18 Kavitha 24 28896 primi 38   4   Idiopathic I M CS FD   A/T/IUGR <7 2.39     
19 Parveen banu 21 28890 primi 37   4.9   Idiopathic S M CS CPD   A/T/SGA >7 2.5     
20 Sakila 30 30620 Primi 40 Anemia 5   IUGR I C VD     A/T/IUGR <7 2.23 AD   
21 Hemalatha 23 30596 G2P1L1 35   3.8   Idiopathic I M CS FI   A/PT/AGA <7 2.9     
22 Kalaivani 25 30641 primi 39   4   Idiopathic I M CS FD   A/T/AGA >7 3.5     
23 Aishwarya 27 31370 primi 36   2.9   Idiopathic S M CS Breech   A/PT/AGA <7 2.19 AD   
24 Tamilselvi 24 31311 G2P1L0 40+1 3.8   PD I C VD     A/T/AGA >7 3.3     
25 Sasirekha 26 30598 Primi 40 PE 4.6   PE I M CS FD   A/T/SGA <7 2.8     
26 Indira 23 29278 Primi 32   NIL   Idiopathic I M CS FD   A/PT/AGA >7 2 AD   
27 Kuttiammal 32 29819 G3P2L1 40+3 4   PD I M CS CPD   A/T/AGA <7 3.2     
28 Lavanya 23 31741 primi 39   5 Microcephaly Anomaly S C VD     A/T/SGA >7 2.6 AD   
29 Arulmozhi 26 31963 primi 34   1.4   Idiopathic S M CS FD   A/PT/AGA <7 2 AD   
30 Muniyammal 23 31227 Primi 40 2.9   Idiopathic I M CS FD   A/T/AGA >7 2.6     
31 Thangam 25 32208 G2P1L1 40+3 Anemia 4.7   PD I M CS CPD   A/T/SGA <7 2.49 AD   
32 Roopa 29 31381 primi 33   3.6 Infantile PCKD Anomaly I C VD     A/PT/SGA >7 2.1 AD   
33 sangeetha 22 32223 primi 39 3.1   Idiopathic S M CS FD   A/T/SGA <7 2.47 AD   
34 Nargis banu 28 32228 G2A1 39 PE 4.2   PE I M CS CPD   A/T/AGA >7 3.4     
35 Anitha 21 32219 Primi 32   2.3   Idiopathic I M CS FD   A/PT/AGA >7 1.4 AD   
36 sumathy 27 32828 Primi 40+2 4.6   PD I M CS FD   A/T/SGA <7 2.7 AD   
37 Bhavani 25 30598 primi 29 PE 3.4   PE S C VD     A/PT/SGA <7 960 gms AD D 
38 Ambika 24 31367 G2P1L0 37   4.5   Idiopathic I C VD     A/T/AGA >7 2.5     
39 Jayanthi 33 32210 Primi 38 2.5   Idiopathic I C VD     A/T/SGA >7 2.48     
  
40 Ammu 21 30596 Primi 40+2   5   PD I M CS FD   A/T/SGA <7 2.61     
41 sarala 27 33509 G3A2 30 APLA 4.1   APLA I C VD     A/PT/SGA >7 1 AD D 
42 Anandhi 25 33831 primi 40+2   5   PD S M CS FI   A/T/SGA <7 2.49     
43 kanniyammal 30 33818 G2P1L1 35 GHT 4.9   GHT S M CS FD   A/PT/AGA >7 2.16 AD   
44 shilpa 20 34690 Primi 40+1 4   PD I C CS FD   A/T/SGA <7 2.475 AD   
45 Revathy 25 34693 Primi 37   3.9   Idiopathic I M CS FD   A/T/AGA >7 3     
46 Karpagam 26 35019 G2P1L0 40+1 3.2   PD I M CS FD   A/T/iUGR >7 2.3 AD   
47 Jothi 22 35698 prim 36 PE 5   PE S C VD     A/PT/SA <7 2.29 AD   
48 Dhivya 26 34980 G3A2 40   4.8   Idiopathic S C OUTLET     A/T/AGA >7 3.24     
49 Rosy 24 36054 primi 37   3.9   IUGR I M CS FD   A/T/IUGR <7 2.21 AD   
50 chitra 22 36418 primi 38   3.1   Idiopathic I M CS FD   A/T/AGA >7 3.12     
51 Kavitha 28 35707 G3P1L1A1 33   2.7   Idiopathic S C VD     A/PT/IUGR <7 1.98 AD D 
52 Murugeshwari 21 36370 primi 40+5 5   PD I M CS CPD   A/T/SGA <7 2.6 AD   
53 Sundarapriya 26 34180 primi 36 Anemia 4.9   IUGR S C VD     A/PT/IUGR >7 1.99 AD D 
54 Kasthuri 23 35695 primi 39   4.8   Idiopathic I C VD     A/T/SGA >7 2.8     
55 Parvathy 34 29276 G2P1L1 40 PE 3.2   PE I M CS FD   A/T/AGA <7 3.43     
56 Jameela 25 36372 primi 37   4   Idiopathic S M CS FD   A/T/SGA >7 2.12 AD   
57 Gomathy 27 38311 primi 40+4 3.1   PD I M CS FD   A/T/AGA >7 3.6     
58 Asha 28 38344 primi 35   4.7   Idiopathic S C VD     A/PT/AGA <7 1.89 AD   
59 Sundari 22 38302 G3P1L1A1 35 PE 3.5   PE I C VD     A/PT/SGA <7 2 AD   
60 Andal 20 36364 primi 40+1 5   PD I M CS FD   A/T/AGA >7 2.6     
61 Muthumari 23 37029 G2A1 34   3.5   Idiopathic S C VD     A/PT/SGA <7 1.765 AD D 
62 Jasmin 27 37684 primi 40 GHT 4   GHT I M CS oblique lie   A/T/AGA >7 2.46     
63 Uma 24 32207 primi 36   2.9   IUGR S C VD     A/PT/IUGR >7 2 AD   
64 Dharani 18 3829 primi 40+3 2.7   PD I M CS FD   A/T/AGA <7 3.5 AD   
65 Porkodi 31 537 primi 37 Anemia 4   Idiopathic S M CS FD   A/T/SGA >7 2.9     
  
66 Bindhu 22 1060 G2P1L0 40+1   3   PD I C VD     A/T/SGA >7 3     
67 Kanaga 29 1582 primi 36 PE 2.7   PE I M CS FD   A/PT/SGA <7 2.2     
68 Poongodi 24 2201 primi 40+3   3.1   PD I M CS FD   A/T/AGA >7 2.38     
69 Mangammal 19 2185 primi 38 PE 3.5   PE I C CS CPD   A/T/SGA >7 2.13 AD   
70 Ganageetham 23 2716 primi 35   2.9   Idiopathic S M CS FD   A/PT/AGA <7 2.1 AD   
71 Sabeena 30 3442 G3P1L0A1 31 APLA 1.7   APLA I C VD     A/PT/SGA <7 1 AD D 
72 Malliga 35 3261 primi 40+6   3.7   PD I M CS FD   A/T/IUGR >7 2.29 AD   
73 Laisha 23 4412 primi 40   5   Idiopathic I M CS FI   A/T/AGA >7 3.35     
74 Jayanthi 28 3260 G2P1L1 36   3   Idiopathic S C OUTLET     A/PT/SGA >7 2.3     
75 Udhayakumari 21 5948 primi 40+3   2.4   PD I M CS FD   A/T/IUGR <7 2.48     
76 Deepadevi 27 6387 primi 38   4.6   Idiopathic I M CS CPD   A/T/AGA >7 3.2     
77 Selviammal 25 5898 primi 37 PE 3.9   PE I C CS FD   A/T/IUGR <7 2.47 AD   
78 Rajathi 20 5888 primi 40+2   4.8   PD I M CS FD   A/T/SGA <7 2.7 AD   
79 samundeeshwari 28 6556 G2A1 34   4.1   Idiopathic I C VD     A/PT/SGA >7 2     
80 Meenatchi 24 6762 primi 39   4   Idiopathic I M CS FD   A/T/AGA <7 3 AD   
81 Vahithabanu 27 7336 primi 40 PE 5   PE I M CS FD   A/T/AGA >7 2.5     
82 Sathya 25 7582 primi 30 PE 3.3   PE I C VD     A/PT/SGA <7 782gms AD D 
83 Malar 19 7590 primi 40   4.9   IUGR I M CS FD   A/T/IUGR >7 2.49 AD   
84 Santhosini 21 7858 G2A1 40+1   4.4   PD I M CS FD   A/T/AGA <7 3.1     
85 Jamuna 26 8160 primi 36   3.5   IUGR S M CS FD   A/PT/IUGR >7 2.2 AD   
86 Ameenabee 33 9694 G3P2L2 38   4.2   Idiopathic I C VD     A/T/AGA >7 3.7     
87 Deepa 25 10700 primi 39 PE 4.4   PE I M CS FD   A/T/SGA <7 2.46 AD   
88 Venkatama 30 11032 G2P1L1 37   5   Idiopathic S M CS FD   A/T/AGA <7 3.15 AD   
89 Geetha 22 10936 primi 40+1   3.7   PD I C VD     A/T/SGA >7 2.6     
90 Sudhasanthi 27 13004 primi 40+5   1.6   PD I C VD     A/T/IUGR <7 2.48 AD   
91 Kalaiselvi 24 13108 G2A1 38   4.6   Idiopathic S M CS CPD   A/T/SGA <7 2.63     
  
92 Rasathi 29 13555 primi 39   3.7 Infantile PCKD Anomaly I M CS CPD   A/T/SGA >7 2.1     
93 Parimala 16 14881 primi 28 PE 5   PE I C VD     A/PT/IUGR <7 796gms AD D 
94 Latha 21 14844 G2P1L1 40+2   2.7   PD I M CS FD   A/T/SGA <7 2.6 AD   
95 Sabeenabegam 19 16823 primi 37   4.2   Idiopathic S M CS FD   A/T/AGA <7 3     
96 Renuka 25 18043 G2A1 40+5   4.8   PD I C CS FD   A/T/SGA >7 2.2 AD   
97 Padmakumari 27 16470 primi 37   4.6   IUGR S M VD     A/T/SGA <7 2.4 AD   
98 Umadevi 24 19316 primi 38   5   Idiopathic I M CS FD   A/T/AGA >7 2.47 AD   
99 Ragal 29 21065 G3P1L1A1 32   5   Idiopathic S C CS FD   A/PT/AGA <7 1.7 AD   
100 Mala 21 21975 primi 39 PE 4.9   PE I M CS FD   A/T/AGA >7 2.49     
101 Poonam 23 21056 primi 40 GHT 2.7   GHT S C VD     A/PT/SGA <7 2.4 AD   
102 Parveen  28 19310 primi 38   5   IUGR S M CS FD   A/T/IUGR >7 2.487 AD   
103 sivaroshini 21 20635 primi 40+5   3.6   PD I C CS FD   A/T/SGA <7 2.4 AD   
104 Muthulakshmi 32 15963 G3A2 39   5   Idiopathic S M CS FD   A/PT/AGA >7 3     
105 Suganya 21 16405 primi 36   5   IUGR S C VD     A/T/IUGR <7 1.9 AD   
106 Deepa 18 14816 primi 40   5   IUGR I M CS FD   A/T/IUGR >7 2.4 AD   
107 Rajeshwari 27 16063 primi 37   4.9   Idiopathic S C CS CPD   A/T/SGA <7 2.37     
108 Dhanalakshmi 24 16823 G2P1L1 40+1   3.4   PD I M CS FD   A/T/SGA <7 2.8 AD   
109 manimala 26 17173 primi 34   5   IUGR S C VD     A/T/IUGR >7 2 AD   
110 zahera 25 16410 primi 40+4   3.9   PD I M CS FD   A/T/SGA <7 2.7 AD   
111 Vimala 30 18043 G2P1L1 40   1.5   IUGR I M CS FD   A/T/IUGR <7 2.46 AD   
112 Thenmozhi 23 17107 primi 38 PE 4.2   PE I C VD     A/PT/AGA <7 2.6 AD   
113 Priyanka 29 16470 G3P1L1A1 39   1.5   IUGR S M CS FD   A/T/IUGR >7 2.39     
114 Datchayani 17 16299 primi 40+4   4.6   PD I C VACCUM     A/T/AGA <7 3     
115 Sumathy 21 17169 primi 32 PE 3.7   PE I C VD     A/PT/IUGR <7 997gms AD D 
116 kalpana 21 15603 G2A1 39   2   IUGR I M CS FD   A/T/IUGR <7 2.3 AD   
117 Rajalakshmi 18 20533 primi 37   4.6   Idiopathic S C VD     A/T/SGA >7 2.5     
  
118 Mageshwari 26 20676 G2P1L1 38   4.2   IUGR I M CS FD   A/T/IUGR <7 2.39 AD   
119 Sudhendra 21 20759 primi 36   4.8   Idiopathic S C CS FD   A/PT/AGA <7 2.6 AD   
120 Reka 30 20753 primi 40+1   3.5   PD I M CS FD   A/T/AGA >7 3.4     
121 Sindhubharathi 25 20874 G2P1L0 34 PE 3.2   PE I M CS FD   A/PT/SGA <7 2.3     
122 Meena 22 20979 primi 40+6   5   PD I C VD     A/T/AGA >7 3.5     
123 Yuvarani 20 21065 primi 37   2.5   IUGR S M CS FD   A/T/IUGR <7 1.9 AD   
124 Sundari 25 20826 G3P2L1 40+1   3   PD I M CS FD   A/T/IUGR <7 2.6 AD   
125 Logeshi 18 21329 primi 37   2.9   Idiopathic S M CS FD   A/T/AGA <7 2.1 AD   
126 Anusia 24 21534 G2P1L1 38   4.5 single UA Anomaly I C VD     A/T/sGA >7 2.67     
127 Rama 31 21615 primi 33 PE 2.3   PE S M CS FD   A/PT/SGA >7 2     
128 Porselvi 22 21975 primi 40+1   4.5   PD I C VD     A/T/AGA <7 2.98     
129 Sofia 24 18538 G3A2 39   5   IUGR S M CS FD   A/T/IUGR <7 2.45 AD   
130 Rasmiya 28 18999 primi 40+1   4.3   PD I M CS FD   A/T/AGA <7 3     
131 Kumari 21 19310 G2P1L1 36   4.1   IUGR S C VD     A/PT/IUGR <7 2.51 AD   
132 Pooja 19 19294 primi 40   2.8   Idiopathic I M CS FD   A/T/AGA <7 3.2     
133 Amirthavalli 25 17814 G2A1 37   4.3   Idiopathic I M CS FD   A/T/SGA <7 2.54     
134 Muniyammal 26 19298 G3P1L1A1 39   4.3   IUGR S C VACCUM     A/T/IUGR <7 2.74     
135 Therasa 24 19361 primi 40+2   3.9   PD I M CS FD   A/T/AGA <7 3.1 AD   
136 Laksmi 21 19276 primi 40+4   5   PD I M CS FD   A/T/SGA >7 2.86     
137 Sumathy 20 19832 primi 38   3.2   IUGR I C VD     A/PT/IUGR <7 1 AD   
138 Priya 23 19974 G2P1L1 40+3   3.6   PD S C OUTLET     A/T/AGA <7 3.13     
139 Manjula 28 19316 G2P1L1 35 PE 5   PE I C VD     A/PT/IUGR >7 820gms AD   
140 Dhanalakshmi 21 20084 primi 40+1   3.2   PD I M CS FD   A/T/SGA <7 2.76     
141 Divya 21 19167 primi 40   3.4   Idiopathic S C VD     A/T/SGA >7 2.68     
142 suganya 27 20335 G2P1L0 36 PE 5   PE I M VD     A/PT/SGA <7 2.4 AD   
143 Kanmani 24 19876 G2P1L1 39   4.3 Infantile PCKD Anomaly S C VD     A/T/IUGR >7 2.72     
  
144 Ramani 20 19453 primi 39   4.9   Idiopathic S C OUTLET     A/PT/SGA <7 1.76 AD   
145 Rasathi 22 19492 primi 40+3   3.7   PD I M CS FD   A/T/AGA >7 3.4     
146 Tamilselvi 19 20341 primi 38   4.2   Idiopathic S C OUTLET     A/T/SGA >7 2.54     
147 Growser 23 20781 G2A1 40+6   5   PD I C CS FI   A/T/AGA <7 2.6     
148 Nagammal 35 21873 primi 37   3.2   Idiopathic S C CS FD   A/T/SGA <7 2.51 AD   
149 Sivasankari 21 21762 primi 40+5   4.1   PD I M CS FD   A/T/AGA <7 3.1     
150 Sankari 25 20845 D2P1L1 39   4.4   Idiopathic I M CS oblique lie   A/T/SGA >7 2.6 AD   
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1 Nabeesha 21 
2199
0 Primi 36 PE 25 Idiopathic   S C VD   PTL 
A/ 
PT/AGA <7 2.6 
 
AD   
2 Muniyammal 26 
2255
2 G2P1L1 39 29 Idiopathic S C VD     A/T/AGA >7 3     
3 sakthi 20 
2185
3 primi 29 Rh neg 34 Rh neg   I C VD   PTL D       D 
4 kalaiyarasi 22 
2256
9 primi 40 GDM 25 GDM   S M CS FD   A/T/AGA >7 3.4     
5 sundari 31 
2279
0 
G3P1L1A
1 37   26 Idiopathic   S C VD     A/T/AGA >7 2.8     
6 Deepika 25 
2289
2 Primi 31   25 Idiopathic   S C VD   PTL 
A/PT/AG
A <7 1.2 AD   
7 sandhiya 21 
2298
3 G2P1L1 38 GHT 27 Idiopathic   S C VD   PROM A/T/AGA >7 3.4     
8 Rasheeda 25 
2291
7 
G5P2L1A
2 39   25 Idiopathic   S C CS 
Cord 
prolapse Cord prolapse A/T/LGA >7 3.2 AD   
9 lalitha 36 
2329
6 Primi 36   32 Anencephaly Anencephaly I C VD     D       D 
10 
Vijayalakshm
i 26 
2345
5 G3A2 41   30 Idiopathic   S M CS Oblique lie   A/T/AGA >7 
3.8
4     
11 Laksmi 29 
2364
6 G2P1L1 40 PE 25 Idiopathic   S C VD     A/T/SGA <7 
3.1
4 AD   
12 devi  24 
2365
7 Primi 30   25 Idiopathic   S C VD   PTL 
A/PT/AG
A <7 1.1 AD D 
13 Kalpana 27 
2377
1 G2P1L0 37   26 Idiopathic   S C 
Vaccum 
forceps   PROM A/T/AGA >7 2.8     
14 Amuthavalli 33 
2368
6 Primi 37   30 Idiopathic   S C CS CPD   A/T/AGA >7 3.1     
  
15 prema 30 
2355
3 
G3P1L1A
1 38 GDM 28 GDM   S M VD     A/T/AGA >7 
3.6
1     
16 Revathy 35 
2383
6 Primi 34 GDM 30 GDM   S C VD   PTL A/T/AGA >7 2     
17 
Kanniyamma
l 28 
2397
3 G3P2L2 39   35 
Diaphragmatic 
hernia 
Diaphragmatic 
hernia S C VD     A/T/SGA <7 
3.0
7 AD D 
18 Angammal 18 
2401
2 G3P2L1 40   25 Idiopathic   S C VD     A/T/AGA >7 3.1     
19 Yuvarani 30 
2394
5 G5P4L3 32   29 Idiopathic   S C VD   Cord prolapse 
A/PT/AG
A >7 1.3 AD D 
20  Nagalakshmi 36 
2414
9 G4p3L3 37   26 Idiopathic   S C VD   PROM A/T/AGA >7 2.6     
21 Nandhini 31 
2361
9 Primi 38   31 Anencephaly Anencephaly I C VD   ATONIC PPH D       D 
22 jayakodi 27 
2411
8 G2P1L0 36 GDM 25 GDM   S C VD     
A/PT/AG
A >7 2.4     
23 Vedavalli 22 
2941
8 G2P1L1 35   29 Idiopathic   S C 
Outlet 
forceps   PTL 
A/PT/AG
A >7 2.2     
24 Sandhiya 26 
2399
3 G2P1L1 32   25 Spina bifida Spina bifida I C VD   PTL D       D 
25 Therasa 20 
2333
3 Primi 39 GHT 26 Idiopathic   S C CS FI PROM A/T/AGA >7 
3.0
9     
26 Rama 38 
2435
9 
G4P2L2A
1 37   27 Idiopathic   S C VD   Cord prolapse A/T/AGA <7 3 AD   
27 Archana 29 
2435
9 
G3P1L1A
1 33   29 Anencephaly Anencephaly I C VD     D       D 
28 Selvi 34 
2482
9 G3P2L1 40   36 Duodenal atresia Duodenal atresia S C VD     A/T/SGA <7 3.8 AD   
29 Parveen  17 
2491
2 Primi 41   25 Idiopathic   S C VD   ATONIC PPH A/T/AGA >7 4.1     
30 Mary 21 
2501
2 G2A1 39 GDM 32 GDM   S C VD     A/T/LGA >7 3.8     
31 Alamelu 28 
2517
6 G2P1L1 38   28 Idiopathic   S M VD     A/T/AGA >7 2.8     
32 Srisha 23 
2533
7 G4P3L1 40   26 Idiopathic   S C 
Outlet 
forceps   PROM A/T/AGA >7 3.2     
33 Guruvamma 25 
2558
6 Primi 39   25 Hydrocephalus  Hydrocephalus S C VD     D       D 
34 Sigappi 27 
2595
2 G2P1L1 32 
Chorioangio
ma 37 Chorioangioma S C VD   
Retained 
placenta D       D 
35 Arivumalar 26 
2611
1 Primi 38 GDM 29 GDM   S M 
Vaccum 
forceps     A/T/AGA <7 4.1 AD   
36 Mala 19 
2630
0 G2P1L1 41   30 Idiopathic S C VD   PROM A/T/LGA <7 
3.2
6 AD   
37 Kavitha 29 
2686
8 
G3P1L1A
1 40   27 Idiopathic   S C VD   PROM A/TAGA >7 3.2     
  
38 Rani 35 
2699
3 Primi 38 GDM 26 GDM   S C CS FD   A/T/AGA <7 
3.4
6 AD   
39 Shanthi 25 
2699
7 G2P1L1 40   25 Idiopathic   I C CS CPD   A/T/LGA >7 
3.1
8     
40 Thendral 26 
2701
6 G2P1L0 40                   PE 25 Idiopathic   S C VD   PROM A/T/SGA >7 3.1     
41 Rajasundari 21 
2693
3 Primi 42   30 Idiopathic   I C 
Outlet 
forceps     A/T/AGA <7 
3.4
6 AD   
42 Velankani 24 
2367
2 G2P1L0 38   27 Idiopathic   S C CS CPD   A/T/AGA >7 
3.3
9     
43 Usha 29 
2478
1 
G3P1L0A
1 40 GDM 29 GDM   S C VD   PROM A/T/AGA >7 4.1 AD   
44 Karpagam 30 
2581
0 G2P1L1 39   26 
Non immune 
hydrops 
Non immune 
hydrops I C VD     D       D 
45 
mathew 
meera 23 
2176
3 G3P2L2 38   27 Idiopathic   S M VD     A/T/AGA >7 
3.1
1     
46 
venketraman
i 22 
2390
8 G2A1 29   25 Hydrocephalus  Hydrocephalus S C VD     D       D 
47 Deepa 26 
2465
4 G4P3L2 39   33 Idiopathic   S C VD     A/T/AGA >7 
3.9
5     
48 Vidhyavathi 29 
2798
3 Primi 39   26 Spina bifida Spina bifida I C VD     D       D 
49 Indhu 27 
2299
0 G2A1 40   26 Idiopathic   S C CS Oblique lie PROM A/T/AGA >7 3.9     
50 Vinodhini 30 
2432
1 G2P1L1 39   31 Anencephaly Anencephaly I C VD     D       D 
 
  
ABBREVIATIONS 
A  -- ALIVE 
AD  - ADMISSION 
AFI  - AMNIOTIC FLUID INDEX 
AGA  - APPROPRIATE FOR GESTATIONAL AGE 
C  - CLEAR 
M  - MECONIUM 
T  - TERM 
PT  - PRETERM 
CPD  - CEPHALO PELVIC DISPROPOTION 
FI  - FAILED INDUCTION 
FD  - FETAL DISTRESS 
GDM  - GESTATIONAL DIABETES MELLITUS  
GHT  - GESTATIONAL HYPERTENSION 
PE  - PREECLAMPSIA 
VD  - VAGINAL DELIVERY 
CS  - CESAREAN SECTION 
S  - SPONTANEOUS 
I  - INDUCED 
PTL  - PRETERM LABOUR 
PROM - PREMATURE RUPTURE OF MEMBRANES 
PPH  - POST PARTUM HEMORR HAGE 
SGA  - SMALL FOR GESTATION  
IUGR - INTRA UTERINE GROWTH RESTRICTION 
D  - DEATH 
PD  - POST DATED 
APLA - ANTIPHOSPHOLIPID ANTIBODY SYNDROME 
